Literature DB >> 15956840

Early arthritis and infection.

Marjatta Leirisalo-Repo1.   

Abstract

PURPOSE OF REVIEW: To summarize the recent literature on the association of infection with early arthritis, and to discuss the possible role of such infections with respect to the development of chronic rheumatic complications. RECENT
FINDINGS: Viral infections are frequently associated with arthritis. Alphaviruses belong to mosquito-borne viruses, one form of which (Sindbis virus) can in Scandinavia and Karelia cause acute arthritis with typical rash. The role of this infection leading to chronic erosive arthritis needs further prospective studies. Patients infected with HIV can have various forms of arthritis. The role of HIV virus as an arthritogenic agent is still debated. On the basis of population studies, Campylobacter infections seem to be increasing as causative infections in reactive arthritis. There is no role for prolonged antibiotic therapy to shorten the duration of acute reactive arthritis, but the possibility that such a treatment might reduce the development of chronic sequelae needs to be examined in a larger study. The role of preceding infection initiating the process of rheumatoid arthritis is still an option, the association being observed in about 20% of patients studied in the early phase of arthritis.
SUMMARY: Viral and microbial infections play a role in acute arthritis. The role of these infections in the development of chronic arthritis needs further prospective controlled studies.

Entities:  

Mesh:

Year:  2005        PMID: 15956840     DOI: 10.1097/01.bor.0000166388.47604.8b

Source DB:  PubMed          Journal:  Curr Opin Rheumatol        ISSN: 1040-8711            Impact factor:   5.006


  14 in total

1.  Glassy dynamics in the adaptive immune response prevents autoimmune disease.

Authors:  Jun Sun; David J Earl; Michael W Deem
Journal:  Phys Rev Lett       Date:  2005-09-29       Impact factor: 9.161

Review 2.  The influence of early life factors on the risk of developing rheumatoid arthritis.

Authors:  A N Colebatch; C J Edwards
Journal:  Clin Exp Immunol       Date:  2010-10-21       Impact factor: 4.330

Review 3.  The role of gut microbiota in immune homeostasis and autoimmunity.

Authors:  Hsin-Jung Wu; Eric Wu
Journal:  Gut Microbes       Date:  2012-01-01

4.  A case of Poncet disease diagnosed with interferon-gamma-release assays.

Authors:  Heikki Valleala; Tamara Tuuminen; Heikki Repo; Kari K Eklund; Marjatta Leirisalo-Repo
Journal:  Nat Rev Rheumatol       Date:  2009-11       Impact factor: 20.543

Review 5.  Host-microbiota interplay in mediating immune disorders.

Authors:  Krysta M Felix; Shekha Tahsin; Hsin-Jung Joyce Wu
Journal:  Ann N Y Acad Sci       Date:  2017-10-06       Impact factor: 5.691

Review 6.  Approach to polyarthritis.

Authors:  Surjit Singh; Sonia Mehra
Journal:  Indian J Pediatr       Date:  2010-08-24       Impact factor: 5.319

Review 7.  Individuality, phenotypic differentiation, dormancy and 'persistence' in culturable bacterial systems: commonalities shared by environmental, laboratory, and clinical microbiology.

Authors:  Douglas Kell; Marnie Potgieter; Etheresia Pretorius
Journal:  F1000Res       Date:  2015-07-01

8.  The Role of MicroRNAs in Human Diseases.

Authors:  Ali M Ardekani; Mozhgan Moslemi Naeini
Journal:  Avicenna J Med Biotechnol       Date:  2010-10

Review 9.  Chronic Gastrointestinal and Joint-Related Sequelae Associated with Common Foodborne Illnesses: A Scoping Review.

Authors:  Kristen Pogreba-Brown; Erika Austhof; Alexandra Armstrong; Kenzie Schaefer; Lorenzo Villa Zapata; D Jean McClelland; Michael B Batz; Maria Kuecken; Mark Riddle; Chad K Porter; Michael C Bazaco
Journal:  Foodborne Pathog Dis       Date:  2019-10-07       Impact factor: 3.788

10.  Inflammatory arthritis can be reined in by CpG-induced DC-NK cell cross talk.

Authors:  Hsin-Jung Wu; Heloisa Sawaya; Bryce Binstadt; Margot Brickelmaier; Amanda Blasius; Leonid Gorelik; Umar Mahmood; Ralph Weissleder; John Carulli; Christophe Benoist; Diane Mathis
Journal:  J Exp Med       Date:  2007-07-23       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.